Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with prostate cancer (specifically the type called adenocarcinoma), confirmed through a tissue sample test
- People whose cancer is classified as intermediate or high risk, based on a standard medical guideline called the NCCN definition
- People whose cancer has not spread to the lymph nodes or other parts of the body, confirmed through scans such as a bone scan, CT scan, or a specialised PET scan
- People who are reasonably active and able to carry out daily activities (rated 0–2 on a standard health scale called the ECOG scale)
- People who, in the treating doctor's opinion, have a life expectancy of more than 5 years
- People whose urinary symptom score (measured by a standard questionnaire called the IPSS) is 19 or below — medication to help with urinary flow is permitted
Who may not be able to join:
- People whose cancer has reached a more advanced local stage, specifically T3b or higher according to a standard cancer staging system (confirm with trial site)
- People whose PSA level has been above 20 ng/ml at any point in time (PSA is a protein measured in a blood test used to monitor prostate cancer)
- People who have previously had surgery to remove or treat the prostate, such as a radical prostatectomy or cryotherapy
- People who have previously had radiotherapy treatment to the pelvic area
- People who have had another type of cancer in the past, unless they have been free of that cancer for at least 5 years
- People who have active Crohn's Disease or Ulcerative Colitis (ongoing inflammatory bowel conditions)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +39 039-2333663
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants with treatment-related adverse events as assessed by CTCAE v.5.0
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.